An yarda da allurar rigakafin rayuwa
Pfizer
Novavax
Moderna
Astra Zeneca
Comirnaty allurar rigakafi ce wacce za ta iya hana mutane yin rashin lafiya sakamakon COVID-19. Comirnaty ba ya ƙunshi ƙwayar cuta mai rai kuma ba zai iya ba ku COVID-19 ba. Ya ƙunshi lambar kwayoyin halitta don wani muhimmin sashi na kwayar cutar SARS-CoV-2, wanda aka sani da sunadaran karu. Bayan karbar maganin alurar riga kafi, jikin ku yana yin kwafin furotin mai karu, kuma tsarin garkuwar jikin ku zai koyi ganewa da yaƙar kwayar cutar SARS-CoV-2 da ke haifarwa.
Kamar yadda har yanzu ba a sami isasshiyar shaida don tantance tasirin wannan allurar a kan watsawa ba, dole ne a ci gaba da aiwatar da matakan kiwon lafiyar jama'a da zamantakewa, gami da rufe fuska, nisantar jiki, wanke hannu, samun iska mai dacewa da sauran matakan, idan ya dace, a wasu wurare, dangane da haka. COVID-19 annoba da yuwuwar haɗarin bambance-bambancen da ke tasowa. Jagorar gwamnati game da matakan kiwon lafiyar jama'a da zamantakewa ya kamata a ci gaba da bin duk waɗanda aka yi wa allurar rigakafi da marasa rigakafi. SAGE za ta sabunta wannan shawarar yayin da aka tantance tasirin rigakafin rigakafin cutar da kuma kariya ta kai tsaye.
Alurar riga kafi na Moderna COVID-19 rigakafin ne na manzon RNA (mRNA) dangane da kwayar cutar coronavirus 2019 (COVID-19). Kwayoyin runduna suna karɓar umarni daga mRNA don samar da furotin na S-antigen, wanda ya keɓanta ga SARS-CoV-2, yana ba da damar jiki don samar da amsawar rigakafi da kuma riƙe wannan bayanin a cikin ƙwayoyin rigakafi na ƙwaƙwalwar ajiya. Tasirin gwaje-gwajen asibiti a cikin mahalarta waɗanda suka karɓi cikakken jerin alluran rigakafi (masu allurai 2) kuma suna da mummunan tushe na SARS-CoV-2 ya kasance kusan 94% dangane da matsakaicin matsakaicin lokacin makonni 9. Bayanan da aka sake dubawa a wannan lokacin suna goyan bayan ƙarshe cewa sanannun kuma yuwuwar fa'idodin rigakafin mRNA-1273 sun fi sananne da haɗarin haɗari. (Sabuntawa yana jiran)
Heading 1
